[Case study] - Losan Pharma has manufactured pharma-inks under #cGMP and delivered to a simulated point-of-care (FABRX) where quality control was conducted while printing. #3dprinting #pharmainnovation
Losan Pharma, a privately owned, international operating CDMO meeting the hightest standard of global quality requirements, is providing solutions to enhance bioavailability, improve the stability of APIs and provide targeted, sustained release delivery of pharmaceutical products. We are glad to inform you that we have implemented several innovative technologies which could help you in the design
Attendees from over 20 countries joined our virtual Scientific Drug Delivery Conference 2022 on Tuesday 15th February to learn about topics specifically related to drug delivery, about nanotechnology and 3D printing. We would like to express our heartfelt thanks to each of the speakers as well as to the participants who gave their time to attend and to contribute.
Only two weeks left - REGISTER now for our #Livestream : 4th Drug Delivery Conference on February 15th | #drugdelivery #nanotechnology #3Dprinting #pharma
Selective Laser Sintering 3D Printing of Orally Disintegrating Printlets Containing Ondansetron
Losan Pharma and FabRx have demonstrated the potential of selective laser sintering 3D printing to fabricate orodispersible printlets with characteristics similar to a commercial orally disintegrating tablet, but with the added benefit of using a manufacturing technology able to prepare medicines ind
Wir sind ein innovatives Pharmatechnologie-Unternehmen das sich auf die Entwicklung und Herstellung moderner Arzneimittelformen mit optimierter Wirkstoffperformance spezialisiert hat.
Als CDMO-Partner der pharmazeutischen Industrie für die Auftragsentwicklung und Auftragsherstellung, bieten wir unseren Kunden seit 1992 innovative Lösungen für feste, halbfeste und flüssige Darreichungsformen. Für unsere Kunden fertigen wir Produkte, die weltweit in über 70 Ländern vertrieben werden. Mit unserer Auftragsanalytik unterstützen wir Pharmaunternehmen jeder Größe bei ihren Herausforderungen im Bereich Rohstoffanalytik bis hin zur Methodenentwicklung und -validierung.
Otto-Hahn-Straße 13
79395 Neuenburg
Deutschland